Arkema S.A. (OTCMKTS:ARKAY – Get Free Report) saw a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 6,400 shares, a growth of 255.6% from the October 31st total of 1,800 shares. Based on an average trading volume of 28,200 shares, the short-interest ratio is presently 0.2 days.
Arkema Stock Down 1.8 %
ARKAY stock traded down $1.41 during trading on Wednesday, reaching $77.64. The stock had a trading volume of 22,157 shares, compared to its average volume of 16,719. The company has a quick ratio of 1.38, a current ratio of 1.86 and a debt-to-equity ratio of 0.38. Arkema has a one year low of $76.21 and a one year high of $114.15. The company’s 50 day moving average is $88.63 and its two-hundred day moving average is $91.21. The company has a market capitalization of $5.91 billion, a price-to-earnings ratio of 8.81, a P/E/G ratio of 0.46 and a beta of 1.27.
Arkema (OTCMKTS:ARKAY – Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The basic materials company reported $2.45 earnings per share (EPS) for the quarter. The business had revenue of $2.63 billion for the quarter. Arkema had a net margin of 3.82% and a return on equity of 7.99%. Equities research analysts forecast that Arkema will post 9.05 EPS for the current year.
Analysts Set New Price Targets
View Our Latest Stock Report on Arkema
Arkema Company Profile
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Further Reading
- Five stocks we like better than Arkema
- How to Invest in the FAANG Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- P/E Ratio Calculation: How to Assess Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is a Special Dividend?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.